TP53 and carcinoma: As some of the MSI-H carcinomas might respond to 5-FU, it was suggested that, as cytoplasmic predominance is the most maspin phenotype of these cases, presence of simultaneous maspin/p53 nuclear positivity might be used to select the MSI-H carcinomas with potential 5-FU benefits [24].